Differentially expressed genes in two LNCaP prostate cancer cell lines reflecting changes during prostate cancer progression

被引:90
作者
Vaarala, MH
Porvari, K
Kyllönen, A
Vihko, P
机构
[1] Univ Oulu, Dept Pathol, Oulu, Finland
[2] Bioctr Oulu, Oulu, Finland
[3] Univ Helsinki, Dept Biosci, Div Biochem, WHO,Collaborating Ctr Res Reprod Hlth, Helsinki, Finland
基金
芬兰科学院;
关键词
D O I
10.1038/labinvest.3780134
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Prostate cancer tends to become transformed to androgen-independent disease over time when treated by androgen-deprivation therapy. We used two variants of the human prostate cancer cell line LNCaP to study gene expression differences during prostate cancer progression to androgen-independent disease. Production of prostate-specific antigen was regarded as a marker of androgen-dependence and loss of prostate-specific antigen was regarded as a marker of androgen-independence. mRNA from both cell lines was used for cDNA microarray screening. Differential expression of several genes was confirmed by Northern blotting. Monoamine oxidase A, an Expressed Sequence Tag (EST) similar to rat P044, and EST AA412049 were highly overexpressed in androgen-dependent LNCaP cells. Tissue-type plasminogen activator, interferon-inducible protein p78 (MxB), an EST similar to galectin-1, follistatin, fatty acid-binding protein 5, EST AA609749, annexin I, the interferon-inducible gene 1-8U, and phospholipase D1 were highly overexpressed in androgen-independent LNCaP cells. All studied genes had low or no expression in PC-3 cells. The EST similar to rat P044, the EST similar to galectin-1, follistatin, annexin I, and the interferon-inducible gene 1-8U were also expressed in benign prostatic hyperplasia tissue. The Y-linked ribosomal protein S4, Mat-8, and EST AA307912 were highly expressed in benign prostatic hyperplasia tissue. Additionally, both confirmation of differential expression in Northern blots and in situ hybridization were carried out for monoamine oxidase A, the EST similar to rat P044, the EST similar to galectin-1, fatty acid-binding protein 5, and the interferon-inducible gene 1-8U. We identified several potential prostate cancer markers, indicating that the method used is a useful tool for the screening of cancer markers, but other methods, such as in situ hybridization, are needed to further investigate the observations.
引用
收藏
页码:1259 / 1268
页数:10
相关论文
共 33 条
  • [1] Bussemakers MJG, 1999, CANCER RES, V59, P5975
  • [2] Chang GTG, 1997, CANCER RES, V57, P4075
  • [4] The genetics of cancer - a 3D model
    Cole, KA
    Krizman, DB
    Emmert-Buck, MR
    [J]. NATURE GENETICS, 1999, 21 (Suppl 1) : 38 - 41
  • [5] DAIGNEAULT L, 1995, CLIN EXP METASTAS, V13, P345
  • [6] Galectin-1 and galectin-3 expression in human prostate tissue and prostate cancer
    Ellerhorst, J
    Troncoso, P
    Xu, XC
    Lee, J
    Lotan, R
    [J]. UROLOGICAL RESEARCH, 1999, 27 (05): : 362 - 367
  • [7] Ellerhorst J, 1999, INT J ONCOL, V14, P217
  • [8] A GENETIC MODEL FOR COLORECTAL TUMORIGENESIS
    FEARON, ER
    VOGELSTEIN, B
    [J]. CELL, 1990, 61 (05) : 759 - 767
  • [9] Antiangiogenic activity of prostate-specific antigen
    Fortier, AH
    Nelson, BJ
    Grella, DK
    Holaday, JW
    [J]. JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1999, 91 (19) : 1635 - 1640
  • [10] The mechanism of cancer-mediated conversion of plasminogen to the angiogenesis inhibitor angiostatin
    Gately, S
    Twardowski, P
    Stack, MS
    Cundiff, DL
    Grella, D
    Castellino, FJ
    Enghild, J
    Kwaan, HC
    Lee, F
    Kramer, RA
    Volpert, O
    Bouck, N
    Soff, GA
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (20) : 10868 - 10872